Exodus Point Capital Management, LP Olema Pharmaceuticals, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.6 Billion
- Q4 2024
A detailed history of Exodus Point Capital Management, LP transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 91,298 shares of OLMA stock, worth $402,624. This represents 0.0% of its overall portfolio holdings.
Number of Shares
91,298
Previous 69,841
30.72%
Holding current value
$402,624
Previous $834,000
36.21%
% of portfolio
0.0%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding OLMA
# of Institutions
161Shares Held
69.2MCall Options Held
235KPut Options Held
1.3K-
Bain Capital Life Sciences Investors, LLC Boston, MA7.47MShares$32.9 Million11.76% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY7.3MShares$32.2 Million1.62% of portfolio
-
Bvf Inc San Francisco, CA5.72MShares$25.2 Million1.25% of portfolio
-
Black Rock Inc. New York, NY4MShares$17.6 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.67MShares$16.2 Million0.05% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $178M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...